发明名称 Tetragalnac containing conjugates and methods for delivery of oligonucleotides
摘要 Disclosed herein is a modular composition comprising 1) an oligonucleotide; 2) one or more tetraGalNAc ligands of Formula (I), which may be the same or different; optionally, 3) one or more linkers, which may be the same or different; and optionally, 4) one or more targeting ligands, solubilizing agents, pharmacokinetics enhancing agents, lipids, and/or masking agents.
申请公布号 US9540639(B2) 申请公布日期 2017.01.10
申请号 US201314398317 申请日期 2013.05.01
申请人 Sirna Therapeutics, Inc. 发明人 Tellers David;Colletti Steven;Dudkin Vadim;Ikemoto Norihiro;Liao Hongbiao;Parish Craig;Pei Tao;Shaw Anthony;Truong Quang;Wang Lijun;Yuan Yu;Zhu Man
分类号 C12N15/113;A61K47/48;C07H15/26 主分类号 C12N15/113
代理机构 LeClairRyan 代理人 Townes Jeffrey N.;LeClairRyan
主权项 1. A modular composition comprising 1) a single stranded or double stranded oligonucleotide; 2) one or more tetraGalNAc ligands of Formula (I), (II) or (III), which may be the same or different: optionally, 3) one or more linkers, which may be the same or different; and optionally, 4) one or more targeting ligands, solubilizing agents, pharmacokinetics enhancing agents, lipids, and/or masking agents, wherein X is —O—, —S—, —CR1R2—or —NR1—, wherein R1 and R2 are each independently selected from the group consisting of hydrogen and C1-C6 alkyl; n is 1 , 2, 3, or 4; and the bond with “” indicates the point of attachment of the tetraGalNAc ligands to the oligonucleotide, either directly or through one or more optionally present linkers.
地址 Cambridge MA US